Drug Trial Radar · NCT00005577
Gemcitabine in Treating Children With Refractory Solid Tumors
Last checked: Nov 20, 2026Latest source record: Feb 5, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
30
Actual
Start
Aug 1996
Primary completion
Sep 2002
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- First posted
- Apr 2, 2004
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 1 year, up to 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase I trial to study the effectiveness of gemcitabine in treating children who have refractory solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
Conditions
- Unspecified Childhood Solid Tumor, Protocol Specific
Interventions
gemcitabine hydrochlorideDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
No primary outcomes listed.
Locations
23 sites in 2 countries. Site status is shown where the registry gives one.
Children's Hospital Los Angeles
Los Angeles, California
Jonsson Comprehensive Cancer Center, UCLA
Los Angeles, California
Cancer Center and Beckman Research Institute, City of Hope
Los Angeles, California
Children's Hospital of Orange County
Orange, California
UCSF Cancer Center and Cancer Research Institute
San Francisco, California
Children's National Medical Center
Washington D.C., District of Columbia
Indiana University Cancer Center
Indianapolis, Indiana
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan
University of Minnesota Cancer Center
Minneapolis, Minnesota
Mayo Clinic Cancer Center
Rochester, Minnesota
Children's Mercy Hospital
Kansas City, Missouri
NYU School of Medicine's Kaplan Comprehensive Cancer Center
New York, New York
Memorial Sloan-Kettering Cancer Center
New York, New York
Herbert Irving Comprehensive Cancer Center
New York, New York
Children's Hospital Medical Center - Cincinnati
Cincinnati, Ohio
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee
University of Texas - MD Anderson Cancer Center
Houston, Texas
Huntsman Cancer Institute
Salt Lake City, Utah
Children's Hospital and Regional Medical Center - Seattle
Seattle, Washington
University of Wisconsin Comprehensive Cancer Center
Madison, Wisconsin
Princess Margaret Hospital for Children
Perth, Western Australia, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.